Updates to real-world evidence framework
NICE have added new sections to our real-world evidence (RWE) framework that consider problems associated with external validity bias. External validity refers to how well the findings from an analytical sample apply to the target population.
New sections include advice on:
- sampling methods
- methods to assess external validity bias
- methods to minimise external validity bias, including transportability methods (when using international data, for example).
The RWE framework describes best practices for planning, conducting and reporting RWE studies, designed to improve the quality and transparency of RWE that companies present to NICE.
You can find out more here.
Next steps on including technology appraisals in guidelines
Earlier this year, NICE ran a public consultation on methods for including our technology appraisal (TA) recommendations within our guidelines. They’ve now published a response to the consultation and updated their interim methods and process statement. The statement sets out how they plan to bring NICE guidance together. This approach aims to support increased adoption of NICE guidance, leading to better outcomes for patients and better use of NHS resources.
Find out more here.
Free online event – reviewing and refining NICE’s highly specialised technologies criteria
Join NICE on Monday 23 September, 2pm to 2:45pm. They’ll be discussing:
- plans to refine and revise the routing criteria to determine which topics progress through NICE’s highly specialised technologies programme
- how this will impact access to treatments for very rare diseases
- how you can share your views about their plans.
Book a place here.
